ID   SU-AmB-3
AC   CVCL_IV31
SY   SU-AMB-3; Stanford University-American Burkitt-3
DR   Wikidata; Q54970703
RX   PubMed=83902;
RX   PubMed=6804087;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_100; Ataxia telangiectasia
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 02-05-24; Version: 7
//
RX   PubMed=83902; DOI=10.1002/1097-0142(197901)43:1<1::AID-CNCR2820430102>3.0.CO;2-M;
RA   Kaplan H.S., Goodenow R.S., Gartner S., Bieber M.M.;
RT   "Biology and virology of the human malignant lymphomas: 1st Milford D.
RT   Schulz Lecture.";
RL   Cancer 43:1-24(1979).
//
RX   PubMed=6804087; DOI=10.1002/1097-0142(19820501)49:9<1817::AID-CNCR2820490914>3.0.CO;2-F;
RA   Grogan T.M., Warnke R.A., Kaplan H.S.;
RT   "A comparative study of Burkitt's and non-Burkitt's 'undifferentiated'
RT   malignant lymphoma: immunologic, cytochemical, ultrastructural,
RT   cytologic, histopathologic, clinical and cell culture features.";
RL   Cancer 49:1817-1828(1982).
//